Hans Beier Ommen

Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized <i>WT1</i> Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study

Daniela Cilloni, Aline Renneville, Fabienne Hermitte et al. · Journal of Clinical Oncology · 2009 · 434 citations · Full text

Medicine, Hematology, Oncology +17

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

Livio Pagano, Jon Salmanton‐García, Francesco Marchesi et al. · Journal of Hematology & Oncology · 2021 · 318 citations · Full text

Medicine, Hematology, Infectious Diseases +13

Molecular MRD status and outcome after transplantation in NPM1-mutated AML

Richard Dillon, Robert K. Hills, Sylvie Freeman et al. · Blood · 2020 · 166 citations · Full text

Medicine, Molecular Biology, Oncology +3

Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias

Hans Beier Ommen, Susanne Schnittger, Jelena Jovanović et al. · Blood · 2009 · 140 citations · Full text

Medicine, Molecular Biology, Oncology +12

Enasidenib vs conventional care in older patients with late-stage mutant-<i>IDH2</i> relapsed/refractory AML: a randomized phase 3 trial

Stéphane de Botton, Pau Montesinos, Andre C. Schuh et al. · Blood · 2022 · 115 citations · Full text

Medicine, Oncology, Pharmacotherapy +14